Churchill Capital (CCXI)
Nasdaq Market Open
Churchill Capital Corp XI is a special purpose acquisition company, or SPAC, formed to take a private business public through a merger, share exchange, asset acquisition, reorganisation, or similar transaction. As a blank check company, it does not operate a commercial business of its own at the time of listing. Its value proposition rests on the sponsor’s ability to identify an attractive target, negotiate a transaction, and complete a business combination within the required timeframe.
The company’s Class A ordinary shares give public investors exposure to the search for a merger partner rather than to an established stream of revenue or earnings. Like other SPACs, Churchill Capital Corp XI is expected to hold IPO proceeds in a trust account while management evaluates potential acquisition candidates. Investors typically focus on the size and quality of the trust, redemption rights, deal terms, sponsor incentives, and the experience of the team behind the vehicle.
Churchill Capital Corp XI belongs to the broader Churchill Capital SPAC franchise, a platform associated with large-scale public-market acquisition vehicles. The company may consider targets across a wide range of industries unless its governing documents or public filings specify a narrower mandate. Until a transaction is announced, the stock is primarily driven by cash-in-trust dynamics, market expectations around the sponsor, and any news about a potential combination. After a merger agreement is signed, the investment case shifts toward the operating profile, valuation, growth prospects, and risks of the proposed target business.
Last updated
- Market Cap
- —
- P/E
- —
- P/FCF
- —
- P/S
- —
- Enterprise Value
- —
- Sector
- —
- Industry
- —
- Address
- 640 FIFTH AVENUE 12TH FLOOR, NEW YORK, NY, 10019
ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
Is ChemoCentryx (CCXI) Stock Outpacing Its Medical Peers This Year?
ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
Why Is Ionis Pharmaceuticals (IONS) Down 5.8% Since Last Earnings Report?
Why Is ChemoCentryx (CCXI) Up 1.4% Since Last Earnings Report?
ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences
Here's Why ChemoCentryx (CCXI) is a Great Momentum Stock to Buy
ChemoCentryx (CCXI) Now Trades Above Golden Cross: Time to Buy?
The Zacks Analyst Blog Highlights Amgen, ChemoCentryx, Mersana Therapeutics, GSK and Vertex Pharmaceuticals
Biotech Stock Roundup: AMGN's Q2 Earnings, CCXI Acquisition & More Updates
Get ready for more merger mania in the pharma sector for the rest of the year
Ocular Therapeutix (OCUL) Reports Q2 Loss, Lags Revenue Estimates
Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx
ChemoCentryx (CCXI) Moves 109.2% Higher: Will This Strength Last?
Will Brickell (BBI) Report Negative Earnings Next Week? What You Should Know
ChemoCentryx to Hold Second Quarter 2022 Financial Results Conference Call on Tuesday, August 9, 2022
ChemoCentryx's (CCXI) Tavneos Aids Growth, Overdependence a Woe
ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director
Financial statements are not available for this listing.
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 10-Q — Churchill Capital Corp XI | View Filing | |
| edgar index | SCHEDULE 13G/A — Churchill Capital Corp XI | View Filing | |
| edgar index | 10-K — Churchill Capital Corp XI | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 3 — Churchill Capital Corp XI | View Filing | |
| edgar index | 3 — Churchill Capital Corp XI | View Filing | |
| edgar index | 8-K — Churchill Capital Corp XI | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — Churchill Capital Corp XI | View Filing | |
| edgar index | SCHEDULE 13G — Churchill Capital Corp XI | View Filing | |
| edgar index | SCHEDULE 13G — Churchill Capital Corp XI | View Filing | |
| edgar index | SCHEDULE 13G/A — Churchill Capital Corp XI | View Filing | |
| edgar index | SCHEDULE 13G — Churchill Capital Corp XI | View Filing | |
| edgar index | 8-K — Churchill Capital Corp XI | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13D — Churchill Capital Corp XI | View Filing | |
| edgar index | SCHEDULE 13G — Churchill Capital Corp XI | View Filing | |
| edgar index | 8-K — Churchill Capital Corp XI | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — Churchill Capital Corp XI | View Filing | |
| edgar index | 8-K — Churchill Capital Corp XI | View Filing | |
| edgar index | 4 — Churchill Capital Corp XI | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — M. Klein Associates, Inc. | View Filing | |
| form 4 | Form 4 — CHURCHILL SPONSOR XI LLC | View Filing | |
| form 4 | Form 4 — Klein Michael Stuart | View Filing | |
| edgar index | 424B4 — Churchill Capital Corp XI | View Filing | |
| edgar index | 8-A12B — Churchill Capital Corp XI | View Filing | |
| edgar index | S-1MEF — Churchill Capital Corp XI | View Filing | |
| edgar index | 3 — Churchill Capital Corp XI | View Filing | |
| edgar index | 3 — Churchill Capital Corp XI | View Filing | |
| edgar index | 3 — Churchill Capital Corp XI | View Filing | |
| edgar index | CERT — Churchill Capital Corp XI | View Filing | |
| edgar index | EFFECT — Churchill Capital Corp XI | View Filing | |
| form 3 | Form 3 — M. Klein Associates, Inc. | View Filing | |
| form 3 | Form 3 — CHURCHILL SPONSOR XI LLC | View Filing | |
| form 3 | Form 3 — Klein Michael Stuart | View Filing | |
| edgar index | S-1/A — Churchill Capital Corp XI | View Filing | |
| edgar index | S-1 — Churchill Capital Corp XI | View Filing | |
| edgar index | DRS — Churchill Capital Corp XI | View Filing |